Cluster headache-like symptoms during treatment with tenofovir disoproxil fumarate and emtricitabine.
Sign Up to like & getrecommendations! Published in 2019 at "AIDS"
DOI: 10.1097/qad.0000000000002198
Abstract: The combination of tenofovir (TFV) disoproxil fumarate and emtricitabine is currently recommended as a first line treatment in HIV care and more recently in preexposure prophylaxis [1]. Headache is one of its frequent adverse effects… read more here.
Keywords: fumarate emtricitabine; disoproxil fumarate; treatment; headache ... See more keywords
Combination Therapy with Tenofovir Disoproxil Fumarate/Emtricitabine/Elvitegravir/Cobicistat Plus Darunavir Once Daily in Antiretroviral-Naive and Treatment-Experienced Patients: A Retrospective Review
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the International Association of Providers of AIDS Care"
DOI: 10.1177/2325957417752260
Abstract: Background: Patients with drug-resistant HIV often require complex antiretroviral regimens. However, combining fixed-dose combination tablets such as tenofovir–disoproxil–fumarate, emtricitabine, and cobicistat-boosted elvitegravir (TDF/FTC/EVG/cobi) with darunavir (DRV) can provide a simple, once-daily (QD), 2-tablet regimen for… read more here.
Keywords: combination; fumarate emtricitabine; disoproxil fumarate; tenofovir disoproxil ... See more keywords